These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25501779)

  • 1. A 15-year review of pediatric toxic epidermal necrolysis.
    Quirke KP; Beck A; Gamelli RL; Mosier MJ
    J Burn Care Res; 2015; 36(1):130-6. PubMed ID: 25501779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M; Burg M; Lin E; Peng D; Garner W
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric toxic epidermal necrolysis: an institutional review of patients admitted to an intensive care unit.
    Hamilton GM; Fish J
    J Burn Care Res; 2013; 34(6):e351-8. PubMed ID: 23816996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric toxic epidermal necrolysis: using SCORTEN and predictive models to predict morbidity when a focus on mortality is not enough.
    Beck A; Quirke KP; Gamelli RL; Mosier MJ
    J Burn Care Res; 2015; 36(1):167-77. PubMed ID: 25559731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital.
    Ferrándiz-Pulido C; García-Fernández D; Domínguez-Sampedro P; García-Patos V
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1153-9. PubMed ID: 21198948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and outcomes in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chi MH; Chung WH; Hui RC; Chen CB; Lu CW; Chiu TM; Ma DH; Wang CW; Yang CY;
    J Dermatol; 2022 Sep; 49(9):895-902. PubMed ID: 35715971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of Biobrane
    Rogers AD; Blackport E; Cartotto R
    Burns; 2017 Nov; 43(7):1464-1472. PubMed ID: 28526303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity and mortality of mucocutaneous diseases in the pediatric population at a tertiary care center.
    Dore J; Salisbury RE
    J Burn Care Res; 2007; 28(6):865-70. PubMed ID: 17925657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Toxic Epidermal Necrolysis: Experience of a Tertiary Burn Center.
    Rizzo JA; Johnson R; Cartie RJ
    Pediatr Dermatol; 2015; 32(5):704-9. PubMed ID: 26227567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA
    J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burn unit care of Stevens Johnson syndrome/toxic epidermal necrolysis: A survey.
    Le HG; Saeed H; Mantagos IS; Mitchell CM; Goverman J; Chodosh J
    Burns; 2016 Jun; 42(4):830-5. PubMed ID: 26810444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of porcine xenografts in patients with toxic epidermal necrolysis.
    Young JB; Gondek SP; Troche M; Summitt JB; Rae L; Thayer WP; Kahn SA
    Burns; 2016 Dec; 42(8):1728-1733. PubMed ID: 27350163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic epidermal necrolysis in a burns centre: a 6-year review.
    Khoo AK; Foo CL
    Burns; 1996 Jun; 22(4):275-8. PubMed ID: 8781718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.
    Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP
    Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study.
    Carrasquillo OY; Santiago-Vazquez M; Cardona R; Cruz-Manzano M; Figueroa LD
    Int J Dermatol; 2019 Nov; 58(11):1293-1299. PubMed ID: 31166019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.